Učitavanje...
The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide
AIM: Off‐label intravitreal injections of bevacizumab (Avastin) have been given for the treatment of neovascular and exudative ocular diseases since May 2005. Since then, the use of intravitreal bevacizumab has spread worldwide, but the drug‐related adverse events associated with its use have been r...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Group
2006
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1857484/ https://ncbi.nlm.nih.gov/pubmed/16854824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.099598 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|